(Q36693173)

15 August 2017

1 reference

title

Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers (English)

1 reference

15 August 2017

0 references

1 reference

Pentti Sipponen

1

1 reference

15 August 2017

David Y Graham

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2007

1 reference

Scandinavian Journal of Gastroenterology

15 August 2017

published in

1 reference

15 August 2017

volume

42

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

2-10

1 reference

Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Changes in acid secretion over the years. A 30-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Ethanol-derived microbial production of carcinogenic acetaldehyde in achlorhydric atrophic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Atrophic progression induced by H. pylori infection is correlated with a changing pepsinogen I value and associated with the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Long term follow up of patients treated for Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

The time to eradicate gastric cancer is now

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Appropriateness of urea breath test: a prospective observational study based on Maastricht 2000 guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Influence of anti-ulcer drugs used in Japan on the result of 13 C-urea breath test for the diagnosis of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Gastric mucosa: long-term outcome after cure of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Possibility of non-invasive diagnosis of gastric mucosal precancerous changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Usefulness of gastric cancer screening using the serum pepsinogen test method

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Histologic and serum risk markers for noncardia early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Low circulating levels of gastrin-17 in patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600863720

10.1080/00365520600863720

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference